Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2007
04/11/2007CN1943667A The Chinese traditional medicinal powder for hemostasia, acesodyne, myogenic, sore, healing and its preparation method
04/11/2007CN1943666A A Chinese/western compound medicine for treatment of and preventing women's colpitis
04/11/2007CN1943665A A Chinese traditional medicinal composition and its preparation method
04/11/2007CN1943664A The Chinese traditional medicinal cream for treatment of eczema
04/11/2007CN1943663A A kind of medicine for treating and preventing women's colpitis
04/11/2007CN1943639A An external use plaster for curing skin burn and scald
04/11/2007CN1943638A An External use medicine for treating skin pigment reduction and its preparing method
04/11/2007CN1943633A Pudilan antiphlogistic granules and its Pudilan antiphlogistic granules prepared by said method
04/11/2007CN1943616A Medicinal composition for treating impetigo herpetifomis
04/11/2007CN1943614A Method for treating scald and burn and plaster by combined Chinese and western medicine
04/11/2007CN1943610A Chinese medicine preparation for traumatic injury and blood stasis and swelling pain
04/11/2007CN1943600A Medicinal composition containing American cockroach and its ethanol extract and new use
04/11/2007CN1943581A External use medicine for treating dermatosis and its preparing method
04/11/2007CN1943572A Oral natural plant formula with anti-sunlight function
04/11/2007CN1943567A Self micro emulsifying composition of tretinoin medicines and its preparing method
04/11/2007CN1943551A External use medicine for treating and controlling chloasma and beauty composition for removing spot and whitening
04/11/2007CN1310032C Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening
04/11/2007CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway
04/11/2007CN1309781C Solid emulsions based on thermoplastic elastomers
04/11/2007CN1309738C Anti IL-8 monoclonal antibody, sequence of its variable region and application
04/11/2007CN1309734C Polypeptides involved in immune response
04/11/2007CN1309733C Pepties from the 16/6id antibody for treating SLE
04/11/2007CN1309717C 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
04/11/2007CN1309710C Pyrimidine derivitive
04/11/2007CN1309704C Anthranyl amides and their use as medicaments
04/11/2007CN1309419C A Blocking monoclonal antibody to VLA-1 and its use
04/11/2007CN1309400C Chinese medicinal composition for skin caring and its application method
04/11/2007CN1309388C Treatment of inflammatory disorders
04/11/2007CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
04/10/2007US7202366 Heterocyclic analogs of diphenylethylene compounds
04/10/2007US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
04/10/2007US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
04/10/2007US7202273 Prevention of menopausal syndrome
04/10/2007US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists
04/10/2007US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure
04/10/2007US7202249 Antagonists of chemokine receptors
04/10/2007US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity
04/10/2007US7202066 Synergistic healing the wounds
04/10/2007US7201931 Using plant extracts
04/10/2007US7201925 Treatment of ungual and subungual diseases
04/10/2007US7201914 May contain a viricide, a bactericide or bacteriostate, and/or an antiinflammatory agent; uses include control of microbial growth on gloved hands
04/10/2007US7201765 Method and apparatus for acne treatment
04/10/2007CA2407100C 1-aroyl-piperidinyl benzamidines
04/10/2007CA2406783C Skin whiteners containing hydroxytetronic acid
04/10/2007CA2379270C External preparation for skin diseases containing nitroimidazole
04/10/2007CA2277172C Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
04/10/2007CA2227977C Use in a composition of an extract of at least one labiate
04/10/2007CA2199844C Compositions for the treatment of skin disorders
04/10/2007CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof
04/10/2007CA2116810C Utilization of 6,6-dimethyl-2-acylcyclohex-4-en-1,3-diones derivatives in the suntan protection domain of cosmetics, compositions containing same, novel derivative and process forits production
04/05/2007WO2007037295A1 Wrinkling prevention or mitigation with adam inhibitor
04/05/2007WO2007037060A1 Composition for acceleration of type i collagen production
04/05/2007WO2007036107A1 An exterior-applied formulation and its preparation methods and uses
04/05/2007WO2007020386A3 Apoe mimetic agents
04/05/2007WO2007003773A3 Use of a yeast extract in the form of an active agent for inducing a synthesis of sirt proteins in skin cells
04/05/2007WO2006136859A3 Indoli zine derivatives and their use as crth2 antagonists
04/05/2007WO2006111633A3 Use of lecithin as a medicament for treating psoriasis
04/05/2007WO2006095098A3 Use of a non-photosynthetic, non-fructifying filamentous bacteria extract as a $g(g)$g(d)t lymphocyte activation and/or protection agent
04/05/2007US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents
04/05/2007US20070078103 Formulations comprising antisense nucleotides to connexins
04/05/2007US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases
04/05/2007US20070077232 Conditioned cell culture medium compositions and methods of use
04/05/2007US20070077208 Pharmaceutical foam
04/05/2007DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen
04/05/2007DE4393944B4 Use of ecdysteroid in cosmetic or dermatological compsns or culture media - to stimulate differentiation of keratinocytes, e.g. for treating psoriasis or ichthyosis and in prepn of skin grafts
04/05/2007DE112004002847T5 Verwendung von Blutplättchen oder blutblättchenreichem Plasma (PRP) Use of platelets or blood platelet-rich plasma (PRP)
04/05/2007CA2624356A1 Skincare products
04/04/2007EP1769821A1 Applicator for the delivery of topical formulations into mucosal cavities
04/04/2007EP1769800A2 Estrogen replacement therapy
04/04/2007EP1768693A1 Use of hmgb1 for wound healing
04/04/2007EP1768661A1 Use of targeted oxidative therapeutic formulation in treatment of burns
04/04/2007EP1768659A1 Use of a fatty acid for preparing a topical composition for allaying inflammatory reactions due to venemous hymenoptera stings
04/04/2007EP1541673B1 Probiotics for pet food applications
04/04/2007EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
04/04/2007EP1532135B1 Nf-kb inhibitors
04/04/2007EP1521586B1 Use of a chrysanthellum indicum extract for the treatment of acne rosacea
04/04/2007EP1487506B1 Preparation for wound healing and prevention of bandage adhesion to the wound
04/04/2007EP1427405B1 Inflammation-inhibiting compounds
04/04/2007EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/04/2007EP1331932B1 Use of xestospongin c for treating or preventing hiv infection
04/04/2007EP1259595B1 Integrin antagonists
04/04/2007EP1098642B1 Diamino-propanol-compounds for treating ischemia
04/04/2007CN1942200A Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages
04/04/2007CN1942194A Spinsyns for wound healing
04/04/2007CN1942178A Topical formulations for the treatment of skin conditions
04/04/2007CN1940075A Recombinant plasmid with human thymosin Beta-4gene
04/04/2007CN1939905A Indole acrylic acid derivative and its use for preparing immune inhibitor
04/04/2007CN1939541A Immunostimulatory nucleic acids
04/04/2007CN1939539A Local prescription for wart, nail-disease treatment and nail care
04/04/2007CN1939535A Composite collagen protein liquid
04/04/2007CN1939529A Compositions and methods for modulating connexin hemichannels
04/04/2007CN1939522A Externally-applied medicinal composition for treating dermatosis and its making method
04/04/2007CN1939519A Externally-applied medicine for treating moist wart dermatosis and its making method
04/04/2007CN1939516A Chinese medicine for treating burn, scald and frostbite
04/04/2007CN1939511A Medicine for treating burn and scald
04/04/2007CN1939504A Chinese-medicinal preparation for treating psoriasis
04/04/2007CN1939498A Chinese-medicinal preparation for treating psoriasis
04/04/2007CN1939496A Chinese-medicinal composition for treating osmidrosis
04/04/2007CN1939488A Externally-applied ointment for treating subcutaneous abscess and its preparation
04/04/2007CN1939482A Chinese-medicinal preparation for treating leucoderma